Medgend Icon

Ledgend of Medicine







discontinued


Tobradex St FDA Approved Drugs

TOBRADEX [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
-
0.1% : 0.3% (ophthalmic suspension/drops)
Novartis Pharms CorpAug 18, 1988
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBRADEX ST [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
-
0.05% : 0.3% (ophthalmic suspension/drops)
Novartis Pharms CorpFeb 13, 2009
  • Use of a combination of tobramycin and dexamethasone to treat ocular inflammation where an infection or risk of infection exists.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

TOBRAMYCIN AND DEXAMETHASONE [DexamethasoneC22H29FO5 : TobramycinC18H37N5O9]
RX
-
0.1% : 0.3% (ophthalmic suspension/drops)
Bausch And LombOct 27, 1999
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.